While we have Amazing Search we also deliver a full complement of artifacts from EDGAR to our clients - here is one example
At Aug. 7, 2026, 5:15 p.m., Pasithea Therapeutics Corp. (CIK: 1841330) reported their Executive Compensation in a recent DEF 14A. Here is the original data:| Name and Principal Position | Year | Salary ($) |
Bonus ($) |
Stock
Awards ($) |
Option Awards ($) (1) |
All
Other Compensation ($) |
Total ($) |
|||||||||||||||||||
| Tiago Reis Marques (2) | 2025 | 533,610 | 493,150 | - | 277,258 | 23,500 | 1,327,518 | |||||||||||||||||||
| Chief Executive Officer | 2024 | 450,000 | - | 22,241 | 167,818 | - | 640,059 | |||||||||||||||||||
| Daniel Schneiderman (3) | 2025 | 386,984 | 306,400 | - | 178,303 | 23,500 | 895,187 | |||||||||||||||||||
| Chief Financial Officer | 2024 | 330,000 | - | - | 100,223 | - | 430,223 | |||||||||||||||||||
| Graeme Currie (4) | 2025 | - | - | - | - | - | - | |||||||||||||||||||
| Chief Development Officer | 2024 | 386,535 | - | - | 48,276 | - | 434,811 | |||||||||||||||||||
| PERSON-NAME | PERSON-TITLE | YEAR | SALARY | BONUS | STOCK | OPTION | NONEQUITY | NQDEFCOMP | OTHER | TOTAL | SEC-NAME | PERSON-CIK | GENDER |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TIAGO REIS MARQUES | CHIEF EXECUTIVE OFFICER | 2025 | 533610 | 493150 | 277258 | 23500 | 1327518 | MARQUES TIAGO | 1875240 | M | |||
| TIAGO REIS MARQUES | CHIEF EXECUTIVE OFFICER | 2024 | 450000 | 22241 | 167818 | 640059 | MARQUES TIAGO | 1875240 | M | ||||
| DANIEL SCHNEIDERMAN | CHIEF FINANCIAL OFFICER | 2025 | 386984 | 306400 | 178303 | 23500 | 895187 | SCHNEIDERMAN DANIEL H | 1565536 | M | |||
| DANIEL SCHNEIDERMAN | CHIEF FINANCIAL OFFICER | 2024 | 330000 | 100223 | 430223 | SCHNEIDERMAN DANIEL H | 1565536 | M | |||||
| GRAEME CURRIE | CHIEF DEVELOPMENT OFFICER | 2025 | CURRIE GRAEME MARTIN | 1965006 | M | ||||||||
| GRAEME CURRIE | CHIEF DEVELOPMENT OFFICER | 2024 | 386535 | 48276 | 434811 | CURRIE GRAEME MARTIN | 1965006 | M |